Strategic Advocates’s iShares US Healthcare ETF IYH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$259K Sell
3,866
-2,703
-41% -$169K 1% 26
2026
Q1
$405K Sell
6,569
-378
-5% -$24.4K 1.79% 15
2025
Q4
$455K Buy
6,947
+87
+1% +$5.49K 0.12% 82
2025
Q3
$403K Buy
6,860
+136
+2% +$7.75K 0.1% 88
2025
Q2
$380K Buy
+6,724
New +$379K 0.11% 88

Other funds holding IYH

Strategic Advocates's IYH Position: Q2 2026 in Review

Strategic Advocates reduced its iShares US Healthcare ETF (IYH) stake by 41% in Q2 2026, selling an estimated $169K and leaving 3,866 shares worth $259K. The position accounts for 1% of the portfolio, ranked #26.

Strategic Advocates first reported a position in IYH in Q2 2025 and has held it in 5 quarters since. The position peaked at $455K in Q4 2025. 530 funds tracked by Wall St. Rank hold IYH as of Q2 2026.

  • Strategic Advocates held 3,866 shares of iShares US Healthcare ETF worth $259K as of Q2 2026.
  • Strategic Advocates sold 2,703 iShares US Healthcare ETF shares in Q2 2026, an estimated $169K.
  • iShares US Healthcare ETF made up 1% of Strategic Advocates's portfolio in Q2 2026, its #26 holding.
  • Strategic Advocates first reported a position in iShares US Healthcare ETF in Q2 2025 and has held it in 5 quarters since.
  • Strategic Advocates's iShares US Healthcare ETF position peaked at $455K in Q4 2025.
  • 530 funds tracked by Wall St. Rank held iShares US Healthcare ETF as of Q2 2026.

Based on Strategic Advocates's 13F filing for Q2 2026, filed 13 Aug 2026.